| Nathan Lorris Bowers, MD | |
|
3801 5th St Se Ste 110, Puyallup, WA 98374-2106 | |
| (253) 845-9585 | |
| (253) 848-1126 |
| Full Name | Nathan Lorris Bowers |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 3801 5th St Se Ste 110, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659752483 | NPI | - | NPPES |
| 2180918 | Medicaid | WA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Multicare Good Samaritan Hospital | Puyallup, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proliance Surgeons Inc Ps | 8527972900 | 388 |
News Archive
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, moderate and severe disease flares were evaluated together. Full details of the phase IIb clinical trial are published in the October issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex C. difficile Assay Kit and the ICEPlex System have received 510(k) clearance from the United States Food and Drug Administration.
United Therapeutics Corporation announced that its subsidiary, Unither Virology, LLC, has been awarded a contract for up to approximately $45 million under a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for studies directed at the development of a broad-spectrum antiviral drug based on its glycobiology antiviral platform.
Many consumers looking for ways to reduce their health care costs are taking potentially dangerous steps such as foregoing prescription drug medications altogether or skipping necessary refills, according to a new survey from Consumer Reports.
› Verified 6 days ago
| Entity Name | Proliance Surgeons Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023170313 PECOS PAC ID: 8527972900 Enrollment ID: O20031119000128 |
News Archive
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, moderate and severe disease flares were evaluated together. Full details of the phase IIb clinical trial are published in the October issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex C. difficile Assay Kit and the ICEPlex System have received 510(k) clearance from the United States Food and Drug Administration.
United Therapeutics Corporation announced that its subsidiary, Unither Virology, LLC, has been awarded a contract for up to approximately $45 million under a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for studies directed at the development of a broad-spectrum antiviral drug based on its glycobiology antiviral platform.
Many consumers looking for ways to reduce their health care costs are taking potentially dangerous steps such as foregoing prescription drug medications altogether or skipping necessary refills, according to a new survey from Consumer Reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Lorris Bowers, MD 3801 5th St Se Ste 110, Puyallup, WA 98374-2106 Ph: (253) 845-9585 | Nathan Lorris Bowers, MD 3801 5th St Se Ste 110, Puyallup, WA 98374-2106 Ph: (253) 845-9585 |
News Archive
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, moderate and severe disease flares were evaluated together. Full details of the phase IIb clinical trial are published in the October issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex C. difficile Assay Kit and the ICEPlex System have received 510(k) clearance from the United States Food and Drug Administration.
United Therapeutics Corporation announced that its subsidiary, Unither Virology, LLC, has been awarded a contract for up to approximately $45 million under a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for studies directed at the development of a broad-spectrum antiviral drug based on its glycobiology antiviral platform.
Many consumers looking for ways to reduce their health care costs are taking potentially dangerous steps such as foregoing prescription drug medications altogether or skipping necessary refills, according to a new survey from Consumer Reports.
› Verified 6 days ago
John T Steedman Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3801 5th St Se, Suite 110, Puyallup, WA 98374 Phone: 253-845-9585 Fax: 253-435-4785 | |
Steven Chas Brack, DO Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3801 5th St Se, Suite 110, Puyallup, WA 98374 Phone: 253-845-9585 Fax: 253-435-4785 | |
Ryan Riel, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11212 Sunrise Blvd E, #201, Puyallup, WA 98374 Phone: 253-697-7550 | |
John C Hung, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 5th St Se, #4200, Puyallup, WA 98372 Phone: 253-697-3450 Fax: 253-697-3470 | |
Paul S Degenfelder, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 5th St Se, Ste 4200, Puyallup, WA 98372 Phone: 253-697-3450 | |
Wendall W Adams, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3801 5th St Se, Suite 110, Puyallup, WA 98374 Phone: 253-845-9585 Fax: 253-435-4785 | |
Justin David Millard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3801 5th St Se Ste 110, Puyallup, WA 98374 Phone: 253-845-9585 Fax: 253-848-1126 |